Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Tokyo - Delayed Quote JPY

Kringle Pharma, Inc. (4884.T)

806.00
-6.00
(-0.74%)
At close: 3:30:00 PM GMT+9
Currency in JPY All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
80.04M
80.04M
69.25M
391.83M
289.76M
Cost of Revenue
--
--
0.00
88.41M
71.60M
Gross Profit
80.04M
80.04M
69.25M
303.42M
218.16M
Operating Expense
897.92M
897.92M
958.01M
729.58M
576.04M
Operating Income
-817.88M
-817.88M
-888.76M
-426.17M
-357.88M
Net Non Operating Interest Income Expense
189.00k
189.00k
-7.24M
-8.18M
-6.61M
Pretax Income
-754.96M
-754.96M
-852.66M
-330.34M
-299.68M
Tax Provision
1.49M
1.49M
1.49M
1.49M
1.49M
Net Income Common Stockholders
-756.45M
-756.45M
-854.15M
-331.83M
-301.17M
Diluted NI Available to Com Stockholders
-756.45M
-756.45M
-854.15M
-331.83M
-301.17M
Basic EPS
-118.21
--
-158.46
-68.33
-72.51
Diluted EPS
-118.21
--
-158.46
-68.33
-72.51
Basic Average Shares
6.40M
--
5.39M
4.86M
4.15M
Diluted Average Shares
6.81M
--
5.39M
4.86M
4.15M
Total Operating Income as Reported
-817.88M
-817.88M
-888.76M
-426.17M
-357.88M
Total Expenses
897.92M
897.92M
958.01M
817.99M
647.64M
Net Income from Continuing & Discontinued Operation
-756.45M
-756.45M
-854.15M
-331.83M
-301.17M
Normalized Income
-756.45M
-756.45M
-854.15M
-331.83M
-301.17M
Interest Income
189.00k
189.00k
88.00k
207.00k
1.00k
Net Interest Income
189.00k
189.00k
-7.24M
-8.18M
-6.61M
EBIT
-817.88M
-817.88M
-888.76M
-426.17M
-357.88M
EBITDA
-817.88M
-817.88M
-888.76M
-426.17M
-357.88M
Reconciled Cost of Revenue
--
--
0.00
88.41M
71.60M
Net Income from Continuing Operation Net Minority Interest
-756.45M
-756.45M
-854.15M
-331.83M
-301.17M
Normalized EBITDA
-817.88M
-817.88M
-888.76M
-426.17M
-357.88M
Tax Rate for Calcs
0.23
0.23
0.23
0.23
0.31
Tax Effect of Unusual Items
0.00
0.00
0.00
0.00
0.00
9/30/2021 - 12/28/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PRTC PureTech Health plc
17.41
-0.51%
 
IKNA Ikena Oncology, Inc.
1.1200
-7.44%
 
EPIX ESSA Pharma Inc.
1.7200
+0.58%
 
PMVP PMV Pharmaceuticals, Inc.
0.8700
-7.34%
 
SEER Seer, Inc.
1.8900
-4.06%
 
HLVX HilleVax, Inc.
1.8800
-2.08%
 
TBPH Theravance Biopharma, Inc.
10.09
-1.94%
 
NERV Minerva Neurosciences, Inc.
1.6100
-8.52%
 
KZR Kezar Life Sciences, Inc.
4.1600
-3.26%
 
GBIO Generation Bio Co.
0.3743
-8.42%